OrbiMed Advisors »

Merus N V shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 206k 59.17

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Enliven Therapeutics (ELVN)
Biogen Idec (BIIB)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Q32 Bio (QTTB)

View all positions for OrbiMed Advisors

Top funds holding Merus N V

Deerfield Management Company
Commodore Capital
Samlyn Capital
Paradigm Biocapital Advisors
Franklin Resources
Federated Investors
Boxer Capital
Lynx1 Capital Management
BlackRock
Holocene Advisors
BlackRock
Morgan Stanley
Driehaus Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Merus N V